Cancer News

Grant supports research into racial, ethnic health disparitiesOct 3, 2018
The National Cancer Institute has awarded $6.3 million dollars Baylor researchers to create new tools to help researchers to better understand the biological causes behind racial and ethnic health disparities in prostate and breast cancers.
Math meets biology to uncover unexpected biorhythmsSep 19, 2018
A novel mathematical approach has uncovered that some animal cells have robust 12-hour cycles of genetic activity, in addition to circadian or 24-hour cycles.
Grant supports identifying leukemia, Down syndrome linkSep 18, 2018
To better understand a predisposition for acute lymphoblastic leukemia in children with Down syndrome, a team of researchers will sequence the genomes of more than 2,000 individuals with Down syndrome.
Breakthrough reveals mutation driving acute myeloid leukemiaSep 10, 2018
Researchers have discovered that the growth of leukemic cells depends on mutant NPM1 gene and its abnormal transport out of the nucleus into the cytoplasm of the cell.
Study: HPV cancer survivors at risk for second HPV cancerSep 7, 2018
A retrospective study found that survivors of HPV-associated cancers have a high incidence of developing second HPV-related cancers.
Research leads to rare ER+ breast cancer mutations insightSep 4, 2018
Researchers conducted the largest analysis to date to establish associations between rare somatic mutations and prognosis in estrogen receptor positive (ER+) breast cancer
New histiocytotic disorder insights may improve therapiesAug 30, 2018
In a review published in New England Journal of Medicine, physician-scientists review the history of Langerhans-cell histiocytosis (LCH) and the recent developments that will help propel the treatment for patients into the realm of personalized medicine.
Non-alcoholic fatty liver disease a risk factor for liver cancerAug 27, 2018
To establish a better understanding of the link between the risk for liver cancer and non-alcoholic fatty liver disease (NAFLD), researchers conducted a large, retrospective study of patients with and without NAFLD.
Baylor awarded CPRIT Grants for research, recruitmentAug 27, 2018
Baylor College of Medicine has been awarded more than $31 million by the Cancer Prevention & Research Institute of Texas (CPRIT) to support new research, core facilities and recruitment of new faculty to support the fight against cancer.
Companies merge to implement Baylor College of Medicine-developed therapies for cancerAug 8, 2018
Researchers have developed a novel therapy for cancer patients that harnesses the patient’s own immune system to fight cancer in a natural way.
Estrogen receptor events linked to breast cancer metastasisAug 7, 2018
Researchers identify estrogen receptor alpha gene (ESR1) translocation events that drive not only therapeutic resistance, but also trigger ER+ breast cancer cells to metastasize.
African-American men needed for prostate cancer studyJul 20, 2018
Baylor College of Medicine is involved in a study to better understand why African American men with prostate cancer are at a higher risk for developing more aggressive forms of the disease.
St. Baldrick’s Foundation awards seven Baylor faculty with pediatric cancer research grantsJul 19, 2018
The St. Baldrick’s Foundation, a volunteer-powered charity dedicated to raising money for childhood cancer research, has awarded seven grants to faculty members at Baylor College of Medicine.
Altered gene regulation is more widespread in cancer than expected Jul 10, 2018
A team of researchers conducted a large-scale study that provides new insights into the mechanisms that can lead to cancer.
How good bacteria keeps your gut healthyJul 3, 2018
New research reveals a cellular mechanism by which good bacteria can help the gut stay healthy.
Baylor launches community breast cancer education eventJun 27, 2018
Baylor College of Medicine has launched Breast Cancer Conversations, a quarterly educational event designed to inform the public about what’s new in breast cancer.
First-in-human clinical trial aims to treat neuroblastomaJun 15, 2018
In a promising development, researchers announced a Phase 1, first-in-human clinical trial of a new form of immunotherapy to treat neuroblastoma using genetically engineered natural killer T cells (NKTs).
Baylor endorses goal to eliminate HPV-related cancersJun 7, 2018
Baylor and each of the National Cancer Institute-designated cancer centers in issuing a joint statement in support of initiatives to eliminate cancers caused by the human papillomavirus (HPV).
DNA repair defect may drive some cancer treatment resistanceMay 25, 2018
Researchers found that defects in selective DNA damage repair pathways can drive endocrine treatment resistance in a subset of estrogen receptor positive breast cancer patients.
Researchers awarded multiple Department of Defense grants in next frontier of breast cancer genomicsMay 24, 2018
The Department of Defense has awarded researchers at Baylor College of Medicine multiple grants to help better understand breast cancer genomics.